As someone who spent their entire academic career, from B.Sc. to M.Sc. to Ph.D., within a Kavli Institute for Nanoscience Discovery (first in Delft and now in Oxford), I’ve had the privilege of seeing firsthand just how beautifully intricate the nanoscale world can be. Now, as my research focuses on lipid nanoparticles for genetic therapeutics and vaccines, I would like to use this platform to advocate for what I believe is one of the most transformative frontiers in modern medicine: the rational design of nanomaterials for therapeutic delivery.
Continue reading